Leo Cancer Care invests in children's experience of radiotherapy, following world-first treatments

Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC

Akeso enrols first patient in global Phase III trial of cadonilimab vs nivolumab in first-line gastric cancer

FDA approves WELIREG and LENVIMA combination for previously treated advanced renal cell carcinoma

AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer

UChicago Medicine completes construction phase of new cancer facility

FDA Advisory Committee votes in favour of GRAIL's Galleri multi-cancer early detection test

Astellas doses first patient in Phase 3 lung cancer study

X-Chem and Relay Therapeutics collaborate on Phase 3 milestone

BoomRay enters exclusive radioligand therapy asset global license agreement with Novartis

AbbVie and Iambic agree collaboration for discovery and development of small molecule therapies

Grunenthal to acquire Stivarga cancer treatment

Precigen announces FDA platform technology designation for AdenoVerse

Enhertu recommended for EU approval in early HER2-positive breast cancer

PureTech receives FDA Fast Track designation for LYT-200 in HR-MDS